Evidence map›Paper›PMID 24860293›Full record

ArticleActa crystallographica. Section E, Structure reports online2013

Ethyl 3-(10-bromo-anthracen-9-yl)-5-methyl-1,2-oxazole-4-carboxyl-ate.

Chun Li, Michael J Campbell, Matthew J Weaver, Nathan S Duncan, Janet L Hunting, Nicholas R Natale

Abstract read
In one paragraph

Article in Acta crystallographica. Section E, Structure reports online, 2013. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. Syntheses and crystal structures of a nitro-anthracene-isoxazole and its oxidation product.Acta crystallographica. Section E, Crystallographic communications · 2022
    Article
  2. Ethyl 5-methyl-3-[11-(pyridin-2-yl)-6,11-di-hydro-6,11-ep-oxy-dibenzo[Acta crystallographica. Section E, Crystallographic communications · 2020
    Article
  3. AIMing towards improved antitumor efficacy.Bioorganic & medicinal chemistry letters · 2015
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Chun LiDepartment of Chemistry, Ithaca College, 953 Danby Road, Ithaca, NY 14850, USA.
Michael J CampbellDepartment of Pharmaceutical & Biomedical Science, The University of Montana, 32 Campus Drive, Missoula, MT 59812, USA.
Matthew J WeaverDepartment of Pharmaceutical & Biomedical Science, The University of Montana, 32 Campus Drive, Missoula, MT 59812, USA.
Nathan S DuncanDepartment of Pharmaceutical & Biomedical Science, The University of Montana, 32 Campus Drive, Missoula, MT 59812, USA.
Janet L HuntingDepartment of Chemistry, Ithaca College, 953 Danby Road, Ithaca, NY 14850, USA.
Nicholas R NataleDepartment of Pharmaceutical & Biomedical Science, The University of Montana, 32 Campus Drive, Missoula, MT 59812, USA.

Funding

THE ROLE OF PULMONARY SUBPOPULATIONS AND TH2 IMMUNITY IN BALB/C SILICOSIS MODELP20RR017670 · NCRR · UNIVERSITY OF MONTANA · PI ROBERTS, KEVAN · 2002 to 2011
$22.0M
Understanding the molecular mechanism of pathogenesis of prion diseasesP20RR015583 · NCRR · UNIVERSITY OF MONTANA · PI KAVANAUGH, MICHAEL PATRICK · 2000 to 2009
$17.6M
NCRR NIH HHS P20 RR015583NCRR NIH HHS P20 RR017670
6 · The paper itself

Abstract

In the title compound, C21H16BrNO3, the mean planes of the anthracene tricycle and isoxazole ring are inclined to each other at a dihedral angle of 72.12 (7)°. The carb-oxy group is slightly out of the isoxazole mean plane, with a maximum deviation of 0.070 (5) Å for the carbonyl O atom. In the crystal, pairs of weak C-H⋯O hydrogen bonds link the mol-ecules into dimers, and weak C-H⋯N inter-actions further link these dimers into corrugated layers parallel to the bc plane.

Identifiers

PMID24860293
PMCPMC4004437

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.